Abstract: Implementations of the disclosed subject matter provide a process for upgrading refinery residue feedstock. Step a) may include introducing the refinery residue feedstock into a fluidized bed reactor as a solid. In step b), the refinery residue feedstock may be heated to a devolatilizing and thermal cracking temperature in the fluidized bed reactor to produce a product stream comprising gaseous hydrocarbons and solid coke. The gaseous hydrocarbons may be subjected to catalytic hydroprocessing, in step c), in the presence of molecular hydrogen to increase the hydrogen to carbon ratio and lower the average molecular weight of the gaseous hydrocarbons. In step d), the gaseous hydrocarbons may be separated from the solid coke. In step e), the gaseous hydrocarbons from step d) may be subjected to further processing to produce at least one of: C1-C3 hydrocarbons, liquefied petroleum gas, naphtha range hydrocarbons, and middle distillate range hydrocarbons.

Abstract: The present disclosure relates to a novel process for the synthesis of stereospecific compounds of Vitamin K2 group in general and Vitamin K2-7. The present disclosure further discloses novel intermediates useful in the synthesis of stereospecific Vitamin K2-7. Compounds of the Vitamin K2 group obtained are crystalline and exhibit well defined melting points.

Abstract: The present invention provides the use of vitamin K2 compositions for the treatment of drug-induced neuropathy. More particularly it is related to the use of vitamin K2-7 compositions for the treatment of drug-induced peripheral neuropathy caused by the drugs used for the treatment of multiple myeloma.

Abstract: The present disclosure relates to a novel process for the synthesis of stereospecific compounds of Vitamin K2 group in general and Vitamin K2-7. The present disclosure further discloses novel intermediates useful in the synthesis of stereospecific Vitamin K2-7. Compounds of the Vitamin K2 group obtained are crystalline and exhibit well defined melting points.

Abstract: Implementations of the disclosed subject matter provide a process for upgrading refinery residue feedstock. Step a) may include introducing the refinery residue feedstock into a fluidized bed reactor as a solid. In step b), the refinery residue feedstock may be heated to a devolatilizing and thermal cracking temperature in the fluidized bed reactor to produce a product stream comprising gaseous hydrocarbons and solid coke. The gaseous hydrocarbons may be subjected to catalytic hydroprocessing, in step c), in the presence of molecular hydrogen to increase the hydrogen to carbon ratio and lower the average molecular weight of the gaseous hydrocarbons. In step d), the gaseous hydrocarbons may be separated from the solid coke. In step e), the gaseous hydrocarbons from step d) may be subjected to further processing to produce at least one of: C1-C3 hydrocarbons, liquefied petroleum gas, naphtha range hydrocarbons, and middle distillate range hydrocarbons.

Abstract: The invention relates to the system (100) for evaluation of user attributes. More particularly, the present invention relates to system for evaluation of user attributes comprising of server (114) comprising of a processor (101), a memory (103), a database (104) containing plurality of user parameters (120), a selection component (106), a classification module (107), wherein the user is evaluated for one or more modules consisting of a generator unit/component (105) based on the user choice of preference of attributes, and evaluate the user for personality traits of the individual. Additionally the invention relates to method of evaluation of user attributes using both physical mode as deck of cards and virtual mode wherein the system (100) is accessed at a user interface on a computing device connected to the server (114) on a network (115).

Abstract: A process for producing liquid hydrocarbon products from a biomass-containing feedstock and/or a biomass-derived feedstock is provided. The process comprises: a) contacting the feedstock with a hydropyrolysis catalyst composition and molecular hydrogen in a hydropyrolysis reactor vessel to produce a product stream comprising a deoxygenated hydrocarbon product, H2O, H2, CO2, CO, C1-C3 gases, char and catalyst fines; b) removing char and catalyst fines from said product stream; c) cooling the remaining product stream to a temperature of no more than 300° C.; and d) hydroconverting all or a portion of said deoxygenated hydrocarbon product in a hydroconversion reactor in the presence of one or more catalyst compositions suitable for the aromatic saturation of the deoxygenated hydrocarbon product and of the H2O, CO2, CO, H2, and C1-C3 gas generated in step a), to produce a product comprising C4+ hydrocarbon product, H2O, CO, CO2, and C1-C3 gases.

Abstract: A process for producing liquid hydrocarbon products from a biomass-containing feedstock and/or a biomass-derived feedstock is provided. The process comprises: a) contacting the feedstock with a hydropyrolysis catalyst composition and molecular hydrogen in a hydropyrolysis reactor vessel to produce a product stream comprising a partially deoxygenated hydrocarbon product, H2O, H2, CO2, CO, C1-C3 gases, char and catalyst fines; b) removing char and catalyst fines from said product stream; c) cooling the remaining product stream to a temperature in the range of from 150 to 400° C.; and d) hydroconverting said partially deoxygenated hydrocarbon product in a hydroconversion reactor in the presence of one or more catalyst compositions suitable for hydrodeoxygenation and aromatic saturation of the partially deoxygenated hydrocarbon product in the presence of H2O, CO2, CO, H2, and C1-C3 gas generated in step a), to produce a vapour phase product comprising a C4+ hydrocarbon product.

Abstract: The present invention provides the use of vitamin K2 compositions for the treatment of drug-induced neuropathy. More particularly it is related to the use of vitamin K2-7 compositions for the treatment of drug-induced peripheral neuropathy caused by the drugs used for the treatment of multiple myeloma.

Abstract: A process for producing methane from a biomass, biomass-containing and/or biomass-derived feedstock is provided. The process comprises: a) providing in a hydropyrolysis reactor vessel a hydropyrolysis catalyst composition, said composition comprising one or more active metals supported on an oxide-based support, said one or more active metals comprising at least one of cobalt and nickel and said one or more active metals being present in total in an amount in the range of from 2 to 75 wt % based on the overall weight of the catalyst composition; b) contacting the feedstock with said hydropyrolysis catalyst composition and molecular hydrogen in said hydropyrolysis reactor vessel, to produce a first product stream comprising char, catalyst fines and gases comprising hydrogen and hydrocarbons, of which hydrocarbons at least 70 wt % is methane and, optionally, CO and CO2; and c) removing said char and catalyst fines from said first product stream.

Abstract: A process for producing liquid hydrocarbon products from a biomass-containing feedstock and/or a biomass-derived feedstock is provided. The process comprises: a) contacting the feedstock with a hydropyrolysis catalyst composition and molecular hydrogen in a hydropyrolysis reactor vessel to produce a product stream comprising a deoxygenated hydrocarbon product, H2O, H2, CO2, CO, C1-C3 gases, char and catalyst fines; b) removing char and catalyst fines from said product stream; c) cooling the remaining product stream to a temperature of no more than 300° C.; and d) hydroconverting all or a portion of said deoxygenated hydrocarbon product in a hydroconversion reactor in the presence of one or more catalyst compositions suitable for the aromatic saturation of the deoxygenated hydrocarbon product and of the H2O, CO2, CO, H2, and C1-C3 gas generated in step a), to produce a product comprising C4+ hydrocarbon product, H2O, CO, CO2, and C1-C3 gases.

Abstract: A process for producing liquid hydrocarbon products from a biomass-containing feedstock and/or a biomass-derived feedstock is provided. The process comprises: a) contacting the feedstock with a hydropyrolysis catalyst composition and molecular hydrogen in a hydropyrolysis reactor vessel to produce a product stream comprising a partially deoxygenated hydrocarbon product, H2O, H2, CO2, CO, C1-C3 gases, char and catalyst fines; b) removing char and catalyst fines from said product stream; c) cooling the remaining product stream to a temperature in the range of from 150 to 400° C.; and d) hydroconverting said partially deoxygenated hydrocarbon product in a hydroconversion reactor in the presence of one or more catalyst compositions suitable for hydrodeoxygenation and aromatic saturation of the partially deoxygenated hydrocarbon product in the presence of H2O, CO2, CO, H2, and C1-C3 gas generated in step a), to produce a vapour phase product comprising a C4+ hydrocarbon product.

Abstract: A process for producing methane from a biomass, biomass-containing and/or biomass-derived feedstock is provided. The process comprises: a) providing in a hydropyrolysis reactor vessel a hydropyrolysis catalyst composition, said composition comprising one or more active metals supported on an oxide-based support, said one or more active metals comprising at least one of cobalt and nickel and said one or more active metals being present in total in an amount in the range of from 2 to 75 wt % based on the overall weight of the catalyst composition; b) contacting the feedstock with said hydropyrolysis catalyst composition and molecular hydrogen in said hydropyrolysis reactor vessel, to produce a first product stream comprising char, catalyst fines and gases comprising hydrogen and hydrocarbons, of which hydrocarbons at least 70 wt % is methane and, optionally, CO and CO2; and c) removing said char and catalyst fines from said first product stream.

Abstract: Sympathovagal balance is essential in maintaining internal homeostasis. Imbalance in this can lead to many disease conditions such as cardiovascular diseases, type 2 diabetes mellitus, high blood pressure, gastroesophageal reflux disease (GERD), IBS, depression, COPD, etc. Sudden cardiac death and Myocardial infarction are result of autonomic dysfunction. Many drugs have been proposed for these conditions but lack in correcting the condition and can themselves produce side effects, such as prolongation of QT interval. Inventors of current invention observed serendipitously that vitamin MK-7 can restore the sympathovagal balance and also have cardio protective effect by shortening of QT interval and prolongation of RR interval. Further to this, it was also observed that vitamin MK-7 improves cardiac output, left ventricular work, HDL cholesterol and reduces blood sugar.

Abstract: A device for non-invasively measuring concentration of one or more analytes in a living subject or a biological sample, wherein the device includes several light sources, a system for controlling the timing and intensity of the light source outputs, a system for passing the light through the subject or sample, a system for measuring the amount of light transmitted, and a system for relating the measurement to the concentration of the analyte in question. The light sources are narrow band sources at different wavelengths, and are capable of being rapidly switched between two levels of intensity. The actual number of light sources required and the wavelengths of the sources are dependent upon the specific analyte being measured.

Abstract: A device for non-invasively measuring concentration of one or more analytes in a living subject or a biological sample, wherein the device includes several light sources, a system for controlling the timing and intensity of the light source outputs, a system for passing the light through the subject or sample, a system for measuring the amount of light transmitted, and a system for relating the measurement to the concentration of the analyte in question. The light sources are narrow band sources at different wavelengths, and are capable of being rapidly switched between two levels of intensity. The actual number of light sources required and the wavelengths of the sources are dependent upon the specific analyte being measured.

Abstract: A device for non-invasively measuring concentration of one or more analytes in a living subject or a biological sample, wherein the device includes several light sources, a system for controlling the timing and intensity of the light source outputs, a system for passing the light through the subject or sample, a system for measuring the amount of light transmitted, and a system for relating the measurement to the concentration of the analyte in question. The light sources are narrow band sources at different wavelengths, and are capable of being rapidly switched between two levels of intensity. The actual number of light sources required and the wavelengths of the sources are dependent upon the specific analyte being measured.